Company / Depreciation & Amortization
Day One Biopharmaceuticals, Inc. Depreciation & Amortization History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$366.0K
FY2025
5-year range
$20.0K / $366.0K
FY2021-FY2025
Trend
+297.8%
vs FY2024
Sector context
#138 of 162
Health Care
What the data says
Depreciation & Amortization changed +298% YoY in FY2025, a notable deviation from the 5-year average annual change of +130%.
Based on SEC 10-K filings.
$366,000 in FY2025 with a 5-year CAGR of +87.0%.
Increased from $36,000 to $366,000 over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +79.8%
- 5-Year CAGR
- +87.0%
- 10-Year CAGR
- -
Sector benchmark
Top 15% in Health CareTop 15% of 162This company $366.0K Sector average $220.5M
▼
-99.8% below sector average
Key checks
Key Insights
- 5-year CAGR of +87.0%, indicating consistent growth.
- In FY2025, depreciation & amortization increased 297.8% year-over-year.
- Ranks #138 out of 162 companies in the Health Care sector.
- Lowest depreciation & amortization in the period was in FY2019.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $366.0K | +297.8% |
| FY2024 | $92.0K | +155.6% |
| FY2023 | $36.0K | -42.9% |
| FY2022 | $63.0K | +215.0% |
| FY2021 | $20.0K | +25.0% |
| FY2020 | $16.0K | - |
| FY2019 | $0 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026